Literature DB >> 33191617

HN1L promotes migration and invasion of breast cancer by up-regulating the expression of HMGB1.

Dechuang Jiao1, Jingyang Zhang1, Ping Chen2, Xuhui Guo1, Jianghua Qiao1, Jiujun Zhu1, Lina Wang1, Zhenduo Lu1, Zhenzhen Liu1.   

Abstract

Recent reports showed that haematological and neurological expressed 1-like (HN1L) gene participated in tumorigenesis and tumour invasion. However, the expression and role of HN1L in breast cancer remain to be investigated. Here, bioinformatics, western blot and immunohistochemistry were used to detect the expression of HN1L in breast cancer. Wound healing, transwell assay, immunofluorescence assay and mass spectrum were used to explore the role and mechanism of HN1L on the migration and invasion of breast cancer, which was confirmed in vivo using a nude mice model. Results showed that HN1L was significantly over-expressed in breast cancer tissues, which was positively correlated with M metastasis of breast cancer patients. Silencing HN1L significantly inhibited the invasion and metastasis of breast cancer cells in vitro and lung metastasis in nude mice metastasis model of breast cancer. Mechanistically, HN1L interacted with HSPA9 and affected the expression of HMGB1, playing a key role in promoting the invasion and metastasis of breast cancer cell. These results suggested that HN1L was an appealing drug target for breast cancer.
© 2020 The Authors. Journal of Cellular and Molecular Medicine published by Foundation for Cellular and Molecular Medicine and John Wiley & Sons Ltd.

Entities:  

Keywords:  HMGB1; HN1L; HSPA9; breast cancer; invasion and metastasis

Year:  2020        PMID: 33191617     DOI: 10.1111/jcmm.16090

Source DB:  PubMed          Journal:  J Cell Mol Med        ISSN: 1582-1838            Impact factor:   5.310


  6 in total

Review 1.  NAADP-binding proteins find their identity.

Authors:  Jonathan S Marchant; Gihan S Gunaratne; Xinjiang Cai; James T Slama; Sandip Patel
Journal:  Trends Biochem Sci       Date:  2021-11-20       Impact factor: 13.807

2.  METTL13 facilitates cell growth and metastasis in gastric cancer via an eEF1A/HN1L positive feedback circuit.

Authors:  Qiong Wu; Qingqing Hu; Yanan Hai; Yandong Li; Yong Gao
Journal:  J Cell Commun Signal       Date:  2022-08-04       Impact factor: 5.908

Review 3.  Targeting HMGB1: An available Therapeutic Strategy for Breast Cancer Therapy.

Authors:  Haonan Dong; Lu Zhang; Suling Liu
Journal:  Int J Biol Sci       Date:  2022-05-09       Impact factor: 10.750

Review 4.  Pyroptosis, a target for cancer treatment?

Authors:  Ying Huang; Jian-Wei Wang; Jiao Huang; Lu Tang; Yun-Hua Xu; Hong Sun; Jie Tang; Guo Wang
Journal:  Apoptosis       Date:  2022-01-22       Impact factor: 4.677

Review 5.  Immunostimulatory Properties of Chemotherapy in Breast Cancer: From Immunogenic Modulation Mechanisms to Clinical Practice.

Authors:  Jinguo Zhang; Shuaikang Pan; Chen Jian; Li Hao; Jie Dong; Qingqing Sun; Hongwei Jin; Xinghua Han
Journal:  Front Immunol       Date:  2022-01-05       Impact factor: 7.561

Review 6.  HSP70s in Breast Cancer: Promoters of Tumorigenesis and Potential Targets/Tools for Therapy.

Authors:  Alexander E Kabakov; Vladimir L Gabai
Journal:  Cells       Date:  2021-12-07       Impact factor: 6.600

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.